Does PANTOPRAZOLE ANHYDROUS Cause Mobility decreased? 337 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 337 reports of Mobility decreased have been filed in association with PANTOPRAZOLE ANHYDROUS. This represents 23.5% of all adverse event reports for PANTOPRAZOLE ANHYDROUS.
337
Reports of Mobility decreased with PANTOPRAZOLE ANHYDROUS
23.5%
of all PANTOPRAZOLE ANHYDROUS reports
289
Deaths
233
Hospitalizations
How Dangerous Is Mobility decreased From PANTOPRAZOLE ANHYDROUS?
Of the 337 reports, 289 (85.8%) resulted in death, 233 (69.1%) required hospitalization, and 270 (80.1%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PANTOPRAZOLE ANHYDROUS. However, 337 reports have been filed with the FAERS database.
What Other Side Effects Does PANTOPRAZOLE ANHYDROUS Cause?
Pain (633)
Rheumatoid arthritis (572)
Asthma (568)
Pyrexia (556)
Hypertension (555)
Rash (551)
Headache (550)
Fatigue (539)
Dyspnoea (509)
Hypersensitivity (498)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which PANTOPRAZOLE ANHYDROUS Alternatives Have Lower Mobility decreased Risk?
PANTOPRAZOLE ANHYDROUS vs PANTOTHENIC ACID
PANTOPRAZOLE ANHYDROUS vs PAPAVERINE
PANTOPRAZOLE ANHYDROUS vs PARACETAMOL
PANTOPRAZOLE ANHYDROUS vs PARATHYROID HORMONE
PANTOPRAZOLE ANHYDROUS vs PARECOXIB